These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28094219)
1. 3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S. aureus: Synthesis, biological evaluation and molecular modelling study. Naik NS; Shastri LA; Joshi SD; Dixit SR; Chougala BM; Samundeeswari S; Holiyachi M; Shaikh F; Madar J; Kulkarni R; Sunagar V Bioorg Med Chem; 2017 Feb; 25(4):1413-1422. PubMed ID: 28094219 [TBL] [Abstract][Full Text] [Related]
2. 1,1'-Carbonyldiimidazole (CDI) Mediated Facile Synthesis, Structural Characterization, Antimicrobial Activity, and in-silico Studies of Coumarin- 3-carboxamide Derivatives. Salar U; Khan KM; Fakhri MI; Hussain S; Tauseef S; Ameer S; Wadood A; Khan H; Perveen S Med Chem; 2018; 14(1):86-101. PubMed ID: 28641525 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents. Hu Y; Shen Y; Wu X; Tu X; Wang GX Eur J Med Chem; 2018 Jan; 143():958-969. PubMed ID: 29232586 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents. Mangasuli SN; Hosamani KM; Devarajegowda HC; Kurjogi MM; Joshi SD Eur J Med Chem; 2018 Feb; 146():747-756. PubMed ID: 29407993 [TBL] [Abstract][Full Text] [Related]
5. Microwave assisted synthesis of dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones. Puttaraju KB; Shivashankar K; Chandra ; Mahendra M; Rasal VP; Venkata Vivek PN; Rai K; Chanu MB Eur J Med Chem; 2013 Nov; 69():316-22. PubMed ID: 24056147 [TBL] [Abstract][Full Text] [Related]
6. Green, unexpected synthesis of bis-coumarin derivatives as potent anti-bacterial and anti-inflammatory agents. Chougala BM; Samundeeswari S; Holiyachi M; Naik NS; Shastri LA; Dodamani S; Jalalpure S; Dixit SR; Joshi SD; Sunagar VA Eur J Med Chem; 2018 Jan; 143():1744-1756. PubMed ID: 29133055 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro biological evaluation of novel coumarin derivatives containing isoxazole moieties on melanin synthesis in B16 cells and inhibition on bacteria. Pang GX; Niu C; Mamat N; Aisa HA Bioorg Med Chem Lett; 2017 Jun; 27(12):2674-2677. PubMed ID: 28476568 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents. Wang SF; Yin Y; Wu X; Qiao F; Sha S; Lv PC; Zhao J; Zhu HL Bioorg Med Chem; 2014 Nov; 22(21):5727-37. PubMed ID: 25306465 [TBL] [Abstract][Full Text] [Related]
9. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity. Liu H; Xia DG; Chu ZW; Hu R; Cheng X; Lv XH Bioorg Chem; 2020 Jul; 100():103907. PubMed ID: 32413631 [TBL] [Abstract][Full Text] [Related]
10. Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities. Li B; Pai R; Di M; Aiello D; Barnes MH; Butler MM; Tashjian TF; Peet NP; Bowlin TL; Moir DT J Med Chem; 2012 Dec; 55(24):10896-908. PubMed ID: 23231076 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors. Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of antibacterial activities of 5,7-dihydroxycoumarin derivatives. Chin YP; Huang WJ; Hsu FL; Lin YL; Lin MH Arch Pharm (Weinheim); 2011 Jun; 344(6):386-93. PubMed ID: 21433055 [TBL] [Abstract][Full Text] [Related]
13. Molecular docking studies and facile synthesis of most potent biologically active N-tert-butyl-4-(4-substituted phenyl)-2-((substituted-2-oxo-2H-chromen-4-yl)methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxamide hybrids: An approach for microwave-assisted syntheses and biological evaluation. Chavan RR; Hosamani KM; Kulkarni BD; Joshi SD Bioorg Chem; 2018 Aug; 78():185-194. PubMed ID: 29579642 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Emami S; Foroumadi A; Faramarzi MA; Samadi N Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241 [TBL] [Abstract][Full Text] [Related]
15. New biscoumarin derivatives: synthesis, crystal structure, theoretical study and antibacterial activity against Staphylococcus aureus. Qu D; Li J; Yang XH; Zhang ZD; Luo XX; Li MK; Li X Molecules; 2014 Nov; 19(12):19868-79. PubMed ID: 25460310 [TBL] [Abstract][Full Text] [Related]
16. Modulation of S. aureus and P. aeruginosa biofilm: an in vitro study with new coumarin derivatives. Das T; Das MC; Das A; Bhowmik S; Sandhu P; Akhter Y; Bhattacharjee S; De UC World J Microbiol Biotechnol; 2018 Nov; 34(11):170. PubMed ID: 30406882 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in silico antibacterial evaluation of coumarin derivatives against MDR strains of Staphylococcus aureus and Escherichia coli. Martin ALAR; De Menezes IRA; Sousa AK; Farias PAM; Dos Santos FAV; Freitas TS; Figueredo FG; Ribeiro-Filho J; Carvalho DT; Coutinho HDM; Fonteles MMF Microb Pathog; 2023 Apr; 177():106058. PubMed ID: 36878333 [TBL] [Abstract][Full Text] [Related]
18. Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: Design, synthesis and antibacterial activity. Liu H; Ren ZL; Wang W; Gong JX; Chu MJ; Ma QW; Wang JC; Lv XH Eur J Med Chem; 2018 Sep; 157():81-87. PubMed ID: 30075404 [TBL] [Abstract][Full Text] [Related]
20. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents. Alagumuthu M; Arumugam S Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]